Novocure Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. USO
2. META
3. NVDA
4. SPY
5. MSFT
6. DCOY
7. VKTX
8. PRGS
9. LGND
10. INNV

Go back to Novocure Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Company Update

Novocure (NVCR) Tops Q4 EPS by 13c

February 23, 2017 6:03 AM EST

Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $30.2 million versus the consensus estimate of $26.97 million.

There were 1,091 active patients on Optune at December 31, 2016, an increase of 486 active patients, or 80 percent, compared to... More